Drug Profile
SC 115
Latest Information Update: 04 Jul 2000
Price :
$50
*
At a glance
- Originator Scotia Holdings [CEASED]
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Viral infections
Most Recent Events
- 04 Jul 2000 Discontinued-Preclinical for Viral infections in United Kingdom (Unknown route)
- 04 Sep 1998 No-Development-Reported for Viral infections in United Kingdom (Unknown route)
- 15 Sep 1995 New profile